Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Corydalis yanhusuo (Tetrahydropalmatine).
Corydalis yanhusuo functions primarily as a potent analgesic and sedative through the antagonism of dopamine D2 receptors and the inhibition of acetylcholinesterase by its primary isoquinoline alkaloid, tetrahydropalmatine.
72301
355.4 g/mol
3.2
(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Corydalis yanhusuo (Tetrahydropalmatine) across standard consumer modalities.
The hygroscopic nature of concentrated isoquinoline extracts requires the use of moisture-resistant excipients like microcrystalline cellulose to prevent clumping and maintain flowability.
The intense bitterness of tetrahydropalmatine necessitates advanced flavor-masking technology and may interfere with pectin cross-linking at high inclusion rates.
The high therapeutic dose required for analgesic efficacy often exceeds the 20-30mg payload limit of standard thin-film polymer matrices.
Ready to launch a product featuring Corydalis yanhusuo (Tetrahydropalmatine)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Corydalis yanhusuo (Tetrahydropalmatine) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Corydalis yanhusuo (Tetrahydropalmatine) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation